{"denoms":[{"counts":[{"groupId":"BG000","value":"38"},{"groupId":"BG001","value":"100"},{"groupId":"BG002","value":"108"},{"groupId":"BG003","value":"113"},{"groupId":"BG004","value":"359"}],"units":"Participants"}],"groups":[{"description":"Patients undergo transoral surgical resection of the oropharyngeal tumor. After transoral surgical resection of the oropharyngeal tumor, low risk patients are under observation.\n\nTransoral surgery: Undergo transoral surgical resection","id":"BG000","title":"Arm S (Surgery) Then Arm A (Low Risk, Observation)"},{"description":"Patients undergo transoral surgical resection of the oropharyngeal tumor. After transoral surgical resection of the oropharyngeal tumor, intermediate risk patients receive low-dose IMRT (50 Gy) QD five days a week for 5 weeks.\n\nTransoral surgery: Undergo transoral surgical resection\n\nintensity-modulated radiation therapy: Undergo standard-dose or low-dose IMRT","id":"BG001","title":"Arm S (Surgery) Then Arm B (Intermediate Risk, Low-dose IMRT)"},{"description":"Patients undergo transoral surgical resection of the oropharyngeal tumor. After transoral surgical resection of the oropharyngeal tumor, intermediate risk patients receive standard-dose IMRT (60 Gy) QD five days a week for 6 weeks.\n\nTransoral surgery: Undergo transoral surgical resection\n\nintensity-modulated radiation therapy: Undergo standard-dose or low-dose IMRT","id":"BG002","title":"Arm S (Surgery) Then Arm C (Intermediate Risk, Standard-dose IMRT)"},{"description":"Patients undergo transoral surgical resection of the oropharyngeal tumor. After transoral surgical resection of the oropharyngeal tumor, high risk patients then receive IMRT (66Gy) QD five days a week for 6-7 weeks. Patients also receive cisplatin IV over 60 minutes or carboplatin over 30 minutes on days 1, 8, 15, 22, 29, 36, and 43 during radiation therapy.\n\nTransoral surgery: Undergo transoral surgical resection\n\nintensity-modulated radiation therapy: Undergo standard-dose or low-dose IMRT\n\ncisplatin: Given IV\n\ncarboplatin: Given IV","id":"BG003","title":"Arm S (Surgery) Then Arm D (High Risk, IMRT, Chemotherapy)"},{"description":"Total of all reporting groups","id":"BG004","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"46","upperLimit":"76","value":"61"},{"groupId":"BG001","lowerLimit":"42","upperLimit":"75","value":"59"},{"groupId":"BG002","lowerLimit":"40","upperLimit":"77","value":"57"},{"groupId":"BG003","lowerLimit":"37","upperLimit":"80","value":"58"},{"groupId":"BG004","lowerLimit":"37","upperLimit":"80","value":"58"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"16"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"40"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"30"},{"groupId":"BG001","value":"95"},{"groupId":"BG002","value":"92"},{"groupId":"BG003","value":"102"},{"groupId":"BG004","value":"319"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"11"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"90"},{"groupId":"BG002","value":"98"},{"groupId":"BG003","value":"100"},{"groupId":"BG004","value":"324"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"9"},{"groupId":"BG004","value":"24"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"9"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"93"},{"groupId":"BG002","value":"97"},{"groupId":"BG003","value":"106"},{"groupId":"BG004","value":"331"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"5"},{"groupId":"BG004","value":"18"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"}],"populationDescription":"Eligible and treated patients"}